课题基金 / 基金详情

Regulation of Cell Death and Inflammation by ISG15 during SARS-CoV2 Infection

Regulation of Cell Death and Inflammation by ISG15 during SARS-CoV2 Infection
SARS-CoV2 感染期间 ISG15 对细胞死亡和炎症的调节
批准号:
10287787
负责人:
Deborah J Lenschow
金额:
$19.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-06-08 至 2023-05-31

项目摘要

项目成果

Deborah J Lenschow的其他基金

相似基金

相关文献

中文摘要
翻译
SARS-CoV2是一种高传染性的新型人类冠状病毒,可导致冠状病毒疾病 2019年(新冠肺炎)。目前,美国已有超过740万人确认感染了 SARS-CoV2和超过21.5万人死亡。重症新冠肺炎的特点是肺性和 全身性炎症和多器官功能障碍,不成比例地影响老年人 病人。SARS-CoV2引发如此严重的致病机制尚不清楚 明白了。最近的临床研究表明,细胞死亡,特别是诱导 坏死性上睑下垂,可能是严重新冠肺炎病的预测因素。主办方通过的机制 限制坏死性上睑下垂的原因尚不清楚。在初步数据中,我们已经表明干扰素诱导 ISG15蛋白是坏死性下垂及其下游炎症的负调控因子 在病毒感染期间的反应。在这项提案中,我们将检验SARS-CoV2病毒的假设 ISG15对呼吸系统坏死性下垂的负性调节作用 上皮细胞。我们将使用体外原代气管上皮细胞(HTECs)和体内的 小鼠采用SARS-CoV2动物模型来提出几个问题,包括:1)SARS-CoV2 CoV2诱导呼吸道上皮细胞坏死性下垂;2)ISG15是否调节坏死性上皮细胞 呼吸道上皮细胞死亡与致炎细胞因子/趋化因子的产生 在SARS-CoV2感染期间?3)坏死性下垂及其被ISG15调控是否有助于 SARS-CoV2的发病机制?总体而言,我们的研究将为我们提供对 SARS-CoV2感染的发病机制和潜在的潜在机制 严重疾病,这可能会指导诊断标志物的发展和未来的努力 对策。
英文摘要
SARS-CoV2 is a highly contagious, novel human coronavirus that causes coronavirus disease 2019 (COVID-19). Currently over 7.4 million people in the US have confirmed infection with SARS-CoV2 and over 215,000 have died. Severe COVID-19 is characterized by pulmonary and systemic inflammation and multi-organ dysfunction, which disproportionally affects elderly patients. The mechanism by which SARS-CoV2 triggers such severe pathogenesis is poorly understood. Recent clinical studies have suggested that cell death, especially the induction of necroptosis, may be predictor of severe COVID-19 disease. The mechanism by which the host restricts necroptosis is unclear. In the preliminary data we have shown that the interferon induced protein, ISG15, acts as a negative regulator of necroptosis and its downstream inflammatory responses during viral infection. In this proposal we will test the hypothesis that SARS-CoV2 induces necroptosis and that ISG15 functions as a negative regulator of necroptosis in respiratory epithelial cells. We will use in vitro primary tracheal epithelial cultures (hTECs) and an in vivo mouse adapted SARS-CoV2 animal model to ask several questions including: 1) Does SARS- CoV2 induce necroptosis in respiratory epithelial cells; 2) Does ISG15 modulate necroptotic cell death as well as proinflammatory cytokine/chemokine production in respiratory epithelial cells during SARS-CoV2 infection?; 3) Does necroptosis and its regulation by ISG15 contribute to SARS-CoV2 pathogenesis? Overall, our studies will provide important insight into the pathogenesis of SARS-CoV2 infection and provide potential insight into mechanisms underlying severe disease, which may direct efforts toward the development of diagnostic markers and future countermeasures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanistic characterization of SARS-CoV2 associated kidney injury
  • 批准号:
    10319713
  • 项目类别:
  • 资助金额:
    $39.38万
  • 财政年份:
    2021
  • 负责人:
    Deborah J Lenschow
  • 依托单位:
Mechanistic characterization of SARS-CoV2 associated kidney injury
  • 批准号:
    10427448
  • 项目类别:
  • 资助金额:
    $39.38万
  • 财政年份:
    2021
  • 负责人:
    Deborah J Lenschow
  • 依托单位:
Mechanistic characterization of SARS-CoV2 associated kidney injury
  • 批准号:
    10619568
  • 项目类别:
  • 资助金额:
    $39.38万
  • 财政年份:
    2021
  • 负责人:
    Deborah J Lenschow
  • 依托单位:
Regulation of Cell Death and Inflammation by ISG15 during SARS-CoV2 Infection
  • 批准号:
    10424558
  • 项目类别:
  • 资助金额:
    $23.63万
  • 财政年份:
    2021
  • 负责人:
    Deborah J Lenschow
  • 依托单位:
海外基金